Patents and New Product Development in the Pharmaceutical and Biotechnology Industries
نویسندگان
چکیده
This paper examines the rationale for intellectual property protection in the development of new pharmaceutical products. Prior survey studies of R&D executives have found that patents play a more critical role in appropriating the benefits of innovation in pharmaceuticals compared to other high tech industries. This paper considers why this is so based on an analysis of the economic characteristics of R&D costs and returns in the pharmaceutical and biotechnology industries. The final section examines recent policy developments and issues surrounding patent lifetime and generic competition in this industry.
منابع مشابه
Presentation of a Novel Model for Evaluation of Commercialization of Research and Development: Case Study of the Pharmaceutical Biotechnology Industry
Abstract Background and scope: The current situation in Iran suggests a good basis for advancement in biotechnology industries because the patents for many hi-tech medicines registered in developed countries are ending. Biosimilar and technology-oriented companies without patents will have the opportunity to enter the biosimilar market and move toward innovative initiatives. The present researc...
متن کاملPresentation of a Novel Model for Evaluation of Commercialization of Research and Development: Case Study of the Pharmaceutical Biotechnology Industry
Abstract Background and scope: The current situation in Iran suggests a good basis for advancement in biotechnology industries because the patents for many hi-tech medicines registered in developed countries are ending. Biosimilar and technology-oriented companies without patents will have the opportunity to enter the biosimilar market and move toward innovative initiatives. The present researc...
متن کاملNew Product Development in the Pharmaceutical Industry: Evidence from Iran
In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly highlighted in the pharmaceutical industry mainly because of a long development-time, low success r...
متن کاملNew Product Development in the Pharmaceutical Industry: Evidence from Iran
In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly highlighted in the pharmaceutical industry mainly because of a long development-time, low success r...
متن کاملAn overview on Intellecual Property Rights in Pharmaceutical and Biotechnology Industries
The role of Intellectual Property Rights (IPR) is very effective in pharmaceutical and biotechnology industries. In pharmaceutical industry regarding health sector it clearly defines the market price of the drugs whereas during recession most company owners were spent their money to build the R&D and also they strengthened the IPR cells. It also clearly defines the patent, patent term restorati...
متن کامل